Xontogeny
Boston · Founded 2016
About Xontogeny
Xontogeny seeks to accelerate the development of life science technologies by providing entrepreneurs with the leadership, strategic guidance and operational support necessary to increase the probability of success in early drug and technology development. Through a differentiated approach, the Xontogeny team partners with the founding scientists and entrepreneurs of new ventures to support their vision while allowing a more efficient development model to benefit company founders and early equity holders.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $15.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2017)
- Website: xontogeny.com
- Phone: (857) 891-0017
Industries & Categories
Biopharma, Biotechnology, Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/xontogeny-21315 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.